Summary
- Current Price
- As of today, AYTU price is $2.59, down -1.89% on
- Current Price All-Time High
- AYTU price is currently -100.00% below its historical high of $11,824,390.00 set on
- Market Cap
- AYTU current market cap is $26M, up +247.71% over the past 365 days
- PE Ratio
- AYTU PE ratio is unknown
- Revenue
- AYTU current annual revenue is $66.38M, up +1.84% year-over-year
- Next Earnings
- As of today, the next earnings release for AYTU has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Aytu BioPharma, Inc. |
| Ticker | NASDAQ: AYTU |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aytubio.com |
| Employees | 102 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.59 | ||
| Price, 1D Change | -1.89% | |
| $26M | ||
| - | ||
| - | ||
| 0.87 | ||
| $66M | ||
| Revenue, 1Y Change | +1.84% | |
| -$2.16 | ||
| EPS, 1Y Change | +24.52% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | RSWN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.16 | ||
| EPS Estimate | N/A | -$1.47 |
| EPS Est. Change | N/A | +32.16% |
| $66.38M | ||
| Revenue Estimate | N/A | $57.06M |
| Revenue Est. Change | N/A | -14.05% |
| $2.59 | ||
| Price Target | - | $8.00 |
| Price Tgt. Change | - | +208.88% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.49 | -$2.86 | -14.90% | |
| $0.15 | -$2.16 | -1,539.73% | |
| -$1.47 | N/A | +32.16% | |
| $0.17 | N/A | +107.87% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $81.33M | $65.18M | -19.85% | |
| $69.15M | $66.38M | -4.01% | |
| $57.06M | N/A | -14.05% | |
| $81.40M | N/A | +22.62% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +110.57% | ||
| +23.33% | ||
| +247.71% | ||
| +251.65% | ||
| +1.84% | ||
| -31.33% | ||
| +24.52% | ||
| +99.85% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.59 | ||
| $2.31 | ||
| SMA 200 vs Price | -10.87% | |
| $2.54 | ||
| SMA 50 vs Price | -2.09% | |
| 0.87 | ||
| $0.15 | ||
| 54.62 | ||
| 40.17% | ||
| 118.61% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $66.38M | ||
| -$2.16 | ||
| $42.15M | ||
| 63.49% | ||
| $2.54M | ||
| 3.82% | ||
| -$14.18M | ||
| -21.36% | ||
| $7.91M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.21 | ||
| 1.26 | ||
| 1.07 | ||
| - | ||
| 3 | ||
| -2.85 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 0.42 | ||
| 1.86 | ||
| 4.75 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $18.97M | ||
| $30.95M | ||
| $124.43M | ||
| $79.18M | ||
| $105.46M | ||
| $63.06M | ||
| $22.94M | ||
| $11.06M | ||
| $10.60M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $80.56M | ||
| $39.61M | ||
| $24.23M | ||
| $0.00 | ||
| $5.38M | ||
| $0.00 | ||
| $437.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$1.94M | ||
| -$2.56M | ||
| $15.44M | ||
| $3.23M | ||
| -$5.17M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Ascendiant Capital | → | |
| Maxim Group | → | |
| Ascendiant Capital | → | |
| Lake Street | ||
| Ascendiant Capital | ||
| Maxim Group | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| Cantor Fitzgerald | ||
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with AYTU
FAQ
What is the ticker symbol for Aytu BioPharma, Inc.?
The ticker symbol for Aytu BioPharma, Inc. is NASDAQ:AYTU
Does Aytu BioPharma, Inc. pay dividends?
No, Aytu BioPharma, Inc. does not pay dividends
What sector is Aytu BioPharma, Inc. in?
Aytu BioPharma, Inc. is in the Healthcare sector
What industry is Aytu BioPharma, Inc. in?
Aytu BioPharma, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Aytu BioPharma, Inc. based in?
Aytu BioPharma, Inc. is headquartered in United States
When did Aytu BioPharma, Inc. go public?
Aytu BioPharma, Inc. initial public offering (IPO) was on September 25, 2008
Is Aytu BioPharma, Inc. in the S&P 500?
No, Aytu BioPharma, Inc. is not included in the S&P 500 index
Is Aytu BioPharma, Inc. in the NASDAQ 100?
No, Aytu BioPharma, Inc. is not included in the NASDAQ 100 index
Is Aytu BioPharma, Inc. in the Dow Jones?
No, Aytu BioPharma, Inc. is not included in the Dow Jones index
When was Aytu BioPharma, Inc. last earnings report?
Aytu BioPharma, Inc.'s most recent earnings report was on September 26, 2025
When does Aytu BioPharma, Inc. report earnings?
The date for Aytu BioPharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- AYTU Official Website aytubio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1385818/000143774925029723/0001437749-25-029723-index.htm
- AYTU Profile on Yahoo Finance finance.yahoo.com/quote/AYTU
- AYTU Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aytu